Evidence map›Paper›PMID 25844088›Full record

ArticleFuture virology2015

Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Juan C Zapata, Maria S Salvato

Abstract read
In one paragraph

Article in Future virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Juan C ZapataInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Maria S SalvatoInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Funding

WRCE Nonhuman Primate CoreU54AI057156 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WALKER, DAVID H · 2003 to 2013
$102.6M
Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI GEDDES, CHRISTOPHER DARREN · 2003 to 2013
$91.5M
A Lassa Vaccine in primates with AIDSR21AI074790 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SALVATO, MARIA S. · 2008 to 2009
$488k
Early Response to Hemorrhagic Fever-Causing ArenavirusesR21AI053619 · NIAID · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI SALVATO, MARIA S. · 2002 to 2003
$409k
Early Response to Agents Causing Flu Like SymptomsR21AI053620 · NIAID · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI SALVATO, MARIA S. · 2002 to 2003
$409k
MOLECULAR BASIS OF ARENAVIRUS VIRULENCER01AI032107 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI SALVATO, MARIA S. · 1994 to 1996
–
NIAID NIH HHS R01 AI032107NIAID NIH HHS R21 AI053619NIAID NIH HHS R21 AI053620NIAID NIH HHS R21 AI074790NIAID NIH HHS U54 AI057156NIAID NIH HHS U54 AI057168
6 · The paper itself

Abstract

Lassa virus infection elicits distinctive changes in host gene expression and metabolism. We focus on changes in host gene expression that may be biomarkers that discriminate individual pathogens or may help to provide a prognosis for disease. In addition to assessing mRNA changes, functional studies are also needed to discriminate causes of disease from mechanisms of host resistance. Host responses that drive pathogenesis are likely to be targets for prevention or therapy. Host responses to Lassa or its related arenaviruses have been monitored in cell culture, in animal models of hemorrhagic fever, in Lassa-infected nonhuman primates and, to a limited extent, in infected human beings. Here, we describe results from those studies and discuss potential targets for reducing virus replication and mitigating disease.

Indexed as

hemorrhagic fever virusesLassa fevertranscriptome profiling

Identifiers

PMID25844088
PMCPMC4383259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.